AR074845A1 - Procedimiento de sintesis de la ivabradina y de sus sales de adicion a un acido farmaceuticamente aceptable - Google Patents
Procedimiento de sintesis de la ivabradina y de sus sales de adicion a un acido farmaceuticamente aceptableInfo
- Publication number
- AR074845A1 AR074845A1 ARP090105037A ARP090105037A AR074845A1 AR 074845 A1 AR074845 A1 AR 074845A1 AR P090105037 A ARP090105037 A AR P090105037A AR P090105037 A ARP090105037 A AR P090105037A AR 074845 A1 AR074845 A1 AR 074845A1
- Authority
- AR
- Argentina
- Prior art keywords
- ivabradine
- pharmaceutically acceptable
- addition salts
- acceptable acid
- synthesis procedure
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
- C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
- C07D217/16—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals substituted by oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Saccharide Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
Reivindicación 1: Procedimiento de síntesis del compuesto de fórmula (1), en forma racémica u ópticamente activa: en la que A representa H2C-CH2 o HC=CH, caracterizado porque se somete el compuesto de fórmula (2), en forma racémica u ópticamente activa: a una reacción de aminación reductora por el compuesto de fórmula (3): en la que A es tal como se ha definido anteriormente, en presencia de un agente de reducción, en un disolvente orgánico o una mezcla de disolventes orgánicos.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0807444A FR2940287B1 (fr) | 2008-12-24 | 2008-12-24 | Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR074845A1 true AR074845A1 (es) | 2011-02-16 |
Family
ID=40823411
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP090105037A AR074845A1 (es) | 2008-12-24 | 2009-12-22 | Procedimiento de sintesis de la ivabradina y de sus sales de adicion a un acido farmaceuticamente aceptable |
Country Status (36)
| Country | Link |
|---|---|
| US (1) | US8097720B2 (es) |
| EP (1) | EP2202225B1 (es) |
| JP (1) | JP5276579B2 (es) |
| KR (1) | KR101064413B1 (es) |
| CN (1) | CN101759643B (es) |
| AR (1) | AR074845A1 (es) |
| AU (1) | AU2009245875B2 (es) |
| BR (1) | BRPI0905147A8 (es) |
| CA (1) | CA2688815C (es) |
| CL (1) | CL2009002201A1 (es) |
| DK (1) | DK2202225T3 (es) |
| EA (1) | EA016405B1 (es) |
| ES (1) | ES2398332T3 (es) |
| FR (1) | FR2940287B1 (es) |
| GE (1) | GEP20125491B (es) |
| HK (1) | HK1145833A1 (es) |
| HR (1) | HRP20121044T1 (es) |
| JO (1) | JO2807B1 (es) |
| MA (1) | MA31498B1 (es) |
| ME (1) | ME02037B (es) |
| MX (1) | MX2009013480A (es) |
| MY (1) | MY148288A (es) |
| NZ (1) | NZ582310A (es) |
| PA (1) | PA8855501A1 (es) |
| PE (1) | PE20100487A1 (es) |
| PL (1) | PL2202225T3 (es) |
| PT (1) | PT2202225E (es) |
| RS (1) | RS52542B (es) |
| SA (1) | SA109310011B1 (es) |
| SG (1) | SG162671A1 (es) |
| SI (1) | SI2202225T1 (es) |
| TW (1) | TWI385153B (es) |
| UA (1) | UA102518C2 (es) |
| UY (1) | UY32311A (es) |
| WO (1) | WO2010072930A1 (es) |
| ZA (1) | ZA200909109B (es) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8212026B2 (en) | 2007-05-30 | 2012-07-03 | Ind-Swift Laboratories Limited | Process for the preparation of ivabradine hydrochloride and polymorph thereof |
| US11244745B2 (en) | 2010-01-22 | 2022-02-08 | Deka Products Limited Partnership | Computer-implemented method, system, and apparatus for electronic patient care |
| US11881307B2 (en) | 2012-05-24 | 2024-01-23 | Deka Products Limited Partnership | System, method, and apparatus for electronic patient care |
| US11164672B2 (en) | 2010-01-22 | 2021-11-02 | Deka Products Limited Partnership | System and apparatus for electronic patient care |
| US10453157B2 (en) | 2010-01-22 | 2019-10-22 | Deka Products Limited Partnership | System, method, and apparatus for electronic patient care |
| US11210611B2 (en) | 2011-12-21 | 2021-12-28 | Deka Products Limited Partnership | System, method, and apparatus for electronic patient care |
| US20110313789A1 (en) | 2010-01-22 | 2011-12-22 | Deka Products Limited Partnership | Electronic patient monitoring system |
| US10911515B2 (en) | 2012-05-24 | 2021-02-02 | Deka Products Limited Partnership | System, method, and apparatus for electronic patient care |
| CN102464595B (zh) * | 2010-11-17 | 2015-02-25 | 山东新时代药业有限公司 | 一种伊伐布雷定中间体的合成方法 |
| FR2971507B1 (fr) * | 2011-02-14 | 2013-01-18 | Servier Lab | Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable |
| EP2495237A1 (en) | 2011-03-04 | 2012-09-05 | Alembic Pharmaceuticals Limited | An improved process for the preparation of highly pure ivabradine hydrochloride |
| FR2984320B1 (fr) * | 2011-12-20 | 2013-11-29 | Servier Lab | Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable |
| FR2984319B1 (fr) * | 2011-12-20 | 2013-12-27 | Servier Lab | Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable |
| CN103848789B (zh) * | 2012-11-29 | 2016-05-18 | 江苏恒瑞医药股份有限公司 | 一种伊伐布雷定的制备方法 |
| CN103864690B (zh) * | 2014-01-06 | 2016-09-14 | 北京莱瑞森医药科技有限公司 | 伊伐布雷定盐酸盐的s晶型、其制备方法和药物组合物 |
| EP3101010A1 (en) | 2015-06-03 | 2016-12-07 | Urquima S.A. | New method for the preparation of highly pure ivabradine base and salts thereof |
| CN113372274B (zh) * | 2020-03-10 | 2023-03-24 | 鲁南制药集团股份有限公司 | 一种伊伐布雷定的制备方法 |
| CN113372273B (zh) * | 2020-03-10 | 2023-05-09 | 鲁南制药集团股份有限公司 | 一种伊伐布雷定中间体化合物iv |
| JP7108650B2 (ja) | 2020-03-11 | 2022-07-28 | 株式会社カナモト | 車両の自動遠隔操縦装置 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2681862B1 (fr) * | 1991-09-27 | 1993-11-12 | Adir Cie | Nouvelles (benzocycloalkyl)alkylamines, leur procede de preparation, et les compositions pharmaceutiques qui les contiennent. |
| FR2868777B1 (fr) * | 2004-04-13 | 2006-05-26 | Servier Lab | Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable |
| FR2868775B1 (fr) * | 2004-04-13 | 2008-04-11 | Servier Lab | Nouveau procede de synthese de derives de la 1,3,4,5- tetrahydro-2h-3-benzazepin-2-one, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable |
| FR2870537A1 (fr) * | 2004-05-19 | 2005-11-25 | Servier Lab | Nouveau procede de synthese du (1s)-4,5-dimethoxy-1-(methyl aminomethyl-)-benzocyclobutane et de ses sels d'addition, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable |
| EP2097383B1 (en) * | 2006-11-30 | 2012-02-08 | Cadila Healthcare Limited | Process for preparation of ivabradine hydrochloride |
| US8212026B2 (en) * | 2007-05-30 | 2012-07-03 | Ind-Swift Laboratories Limited | Process for the preparation of ivabradine hydrochloride and polymorph thereof |
-
2008
- 2008-12-24 FR FR0807444A patent/FR2940287B1/fr not_active Expired - Fee Related
-
2009
- 2009-12-04 SG SG200908061-5A patent/SG162671A1/en unknown
- 2009-12-04 PE PE2009001290A patent/PE20100487A1/es active IP Right Grant
- 2009-12-08 UY UY0001032311A patent/UY32311A/es not_active Application Discontinuation
- 2009-12-09 AU AU2009245875A patent/AU2009245875B2/en not_active Ceased
- 2009-12-10 CA CA2688815A patent/CA2688815C/fr not_active Expired - Fee Related
- 2009-12-10 MX MX2009013480A patent/MX2009013480A/es active IP Right Grant
- 2009-12-11 MY MYPI20095312A patent/MY148288A/en unknown
- 2009-12-16 MA MA32424A patent/MA31498B1/fr unknown
- 2009-12-17 TW TW098143420A patent/TWI385153B/zh not_active IP Right Cessation
- 2009-12-17 JO JO2009485A patent/JO2807B1/en active
- 2009-12-18 EA EA200901563A patent/EA016405B1/ru not_active IP Right Cessation
- 2009-12-18 GE GEAP200911610A patent/GEP20125491B/en unknown
- 2009-12-21 ZA ZA200909109A patent/ZA200909109B/en unknown
- 2009-12-22 UA UAA200913368A patent/UA102518C2/ru unknown
- 2009-12-22 CL CL2009002201A patent/CL2009002201A1/es unknown
- 2009-12-22 AR ARP090105037A patent/AR074845A1/es not_active Application Discontinuation
- 2009-12-22 SA SA109310011A patent/SA109310011B1/ar unknown
- 2009-12-23 EP EP09290990A patent/EP2202225B1/fr active Active
- 2009-12-23 WO PCT/FR2009/001480 patent/WO2010072930A1/fr active Application Filing
- 2009-12-23 NZ NZ582310A patent/NZ582310A/en not_active IP Right Cessation
- 2009-12-23 DK DK09290990.2T patent/DK2202225T3/da active
- 2009-12-23 PT PT09290990T patent/PT2202225E/pt unknown
- 2009-12-23 US US12/655,087 patent/US8097720B2/en not_active Expired - Fee Related
- 2009-12-23 CN CN2009102636114A patent/CN101759643B/zh not_active Expired - Fee Related
- 2009-12-23 ME MEP-2012-526A patent/ME02037B/me unknown
- 2009-12-23 SI SI200930409T patent/SI2202225T1/sl unknown
- 2009-12-23 PL PL09290990T patent/PL2202225T3/pl unknown
- 2009-12-23 PA PA20098855501A patent/PA8855501A1/es unknown
- 2009-12-23 RS RS20120526A patent/RS52542B/en unknown
- 2009-12-23 BR BRPI0905147A patent/BRPI0905147A8/pt not_active IP Right Cessation
- 2009-12-23 ES ES09290990T patent/ES2398332T3/es active Active
- 2009-12-24 KR KR1020090130714A patent/KR101064413B1/ko active IP Right Grant
- 2009-12-24 JP JP2009291676A patent/JP5276579B2/ja active Active
-
2010
- 2010-12-29 HK HK10112196.5A patent/HK1145833A1/xx not_active IP Right Cessation
-
2012
- 2012-12-18 HR HRP20121044AT patent/HRP20121044T1/hr unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR074845A1 (es) | Procedimiento de sintesis de la ivabradina y de sus sales de adicion a un acido farmaceuticamente aceptable | |
| AR116907A2 (es) | Derivado de diazabiciclooctano ópticamente activo y proceso para su preparación | |
| CY1119991T1 (el) | Μεθοδος για την παραγωγη 2-[4-(3- ή 2-φθοροβενζυλοξυ)βενζυλαμινο]προπαναμιδιων με υψηλο βαθμο καθαροτητας | |
| AR075227A1 (es) | Procedimiento de sintesis de ivabradina y sus sales de adicion de acidos farmaceuticamente aceptables. | |
| AR079491A1 (es) | Metodos de sintesis de inhibidores del factor xa tal como el betrixaban y composiciones farmaceuticas que contienen la base libre de betrixaban o su sal sustancialmente pura. | |
| BR112014015363A2 (pt) | derivados de ácido alfa-amino borônico, inibidores de imunoproteassoma seletivos | |
| CL2009000089A1 (es) | Procesos de preparacion de un derivado del acido y-amino-o-bifenil-x-metil-pentanoico;compuestos intermediarios y su proceso de preparacion; uso de los compuestos en la sintesis de compuestos inhibidores de nep, utiles en enfermedades cardiovasculares, tales como hipertension, insuficiencia cardiaca congestiva, entre otras. | |
| CL2009001414A1 (es) | Procedimiento de sintesis de 7,8-dimetoxi-1,3-dihidro-2h-3-benzazepin-2-ona sin aislacion de compuestos intermediarios; util para la sintesis de ivabradina. | |
| PA8840901A1 (es) | Nuevo procedimiento de resolución de enantiómeros de (3,4-dimetoxi-biciclo[4.2.0]octa-1,3,5-trien-7-il, aplicación en la sistesis de ivabradina | |
| CL2011000296A1 (es) | Proceso de preparación del ester metílico del ácido 4-oxo-octahidro-indol-1-carboxílico y compuestos intermediarios utilizados. | |
| AR075978A1 (es) | Procedimiento de sintesis de ivabradina y de sus sales de adicion a un acido farmaceuticamente aceptable | |
| AR107494A1 (es) | Proceso para la preparación de osimertinib (azd9291) o una sal del mismo, y azd9291 anilina o una sal de la misma | |
| AR109248A1 (es) | Procedimiento para la preparación de 4-fenilbutirato y sus usos | |
| ES2571043T3 (es) | Preparación de dihidropiridinas | |
| CO6361921A2 (es) | 3-aminociclopentancarboxamidas | |
| AR047686A1 (es) | Un procedimiento de sintesis de compuestos de 1,3-dihidro-2h-3-benzazepin-2-ona, y su aplicacion a la sintesis de la ivabradina y sus sales de adicion con un acido farmaceuticamente aceptable | |
| MX2010009926A (es) | Nuevo proceso para la preparacion de derivados de acido ciclohexancarboxilico. | |
| MX2010009876A (es) | Nuevo proceso para la preparacion de derivados de acido ciclohexanocarboxilico por medio del derivado de ciclohexanocarboxamida correspondiente. | |
| CL2010000254A1 (es) | Procedimiento de sintesis de ivabradina por formacion de una imina; y los compuestos intermediarios considerados en el procedimiento. | |
| AR087345A1 (es) | Metodos para la preparacion de compuestos de tiofeno | |
| AR066054A1 (es) | Proceso para preparar galantamina | |
| PE20120576A1 (es) | Nuevo procedimiento de sintesis de la ivabradina y de sus sales de adicion farmaceuticamente aceptable | |
| AR088678A1 (es) | Procedimiento de sintesis de la ivabradina y de sus sales de adicion a un acido farmaceuticamente aceptable | |
| UY35108A (es) | Nuevo procedimiento de síntesis del (2e)-3-(3,4-dimetoxifenil) prop-2-enonitrilo, y aplicación a la síntesis de la ivabradina y de sus sales de adición a un ácido farmacéuticamente aceptable | |
| AR093807A1 (es) | Procedimiento de sintesis del 3-(2-bromo-4,5-dimetoxifenil)propanonitrilo, y aplicacion a la sintesis de la ivabradina y de sus sales de adicion a un acido farmaceuticamente aceptable |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |